These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3976647)

  • 1. Platelet transfusion therapy in acute leukemia: lack of effect of splenomegaly on transfusion requirements and risk of hemorrhage.
    Witzig TE; Ducatman BS; Wick MR; Letendre L; Moore SB; Ilstrup DM; Taswell HF
    Am J Hematol; 1985 Apr; 18(4):345-50. PubMed ID: 3976647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of platelet-transfusion therapy administered to patients with acute leukemia.
    Kutti J; Zaroulis CG; Dinsmore RE; Reich L; Clarkson BD; Good RA
    Transfusion; 1982; 22(1):44-7. PubMed ID: 7064206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet transfusions administered to patients with splenomegaly.
    Hussein MA; Lee EJ; Schiffer CA
    Transfusion; 1990; 30(6):508-10. PubMed ID: 2378022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
    Lee EJ; Schiffer CA
    Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy.
    Aderka D; Praff G; Santo M; Weinberger A; Pinkhas J
    Am J Med Sci; 1986 Mar; 291(3):147-51. PubMed ID: 3456706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of clinical status on the efficacy of stored platelet transfusion].
    Norol F; Kuentz M; Cordonnier C; Beaujean F; Haiouin C; Vernant JP; Duedari N
    Rev Fr Transfus Hemobiol; 1993 Oct; 36(5):427-37. PubMed ID: 8259953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that circulating immune complexes remove transfused platelets from the circulation.
    Kutti J; Zaroulis CG; Safai-Kutti S; Dinsmore RE; Day NK; Good RA
    Am J Hematol; 1981 Nov; 11(3):255-9. PubMed ID: 7315840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for platelet transfusion in children with acute leukemia.
    Murphy S; Litwin S; Herring LM; Koch P; Remischovsky J; Donaldson MH; Evans AE; Gardner FH
    Am J Hematol; 1982 Jun; 12(4):347-56. PubMed ID: 6981349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-transfusional platelet increment: effect of clinical factors].
    Muggenthaler KH; Böck M; Heim MU; Mempel W
    Beitr Infusionsther Transfusionsmed; 1994; 32():467-9. PubMed ID: 9480144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet transfusion therapy in thrombocytopaenia of haematologic malignancies.
    Charak BS; Rao K; Parikh PM; Rawat RS; Nair CN; Advani SH
    J Assoc Physicians India; 1989 Mar; 37(3):201-3. PubMed ID: 2768161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Gurevich-Shapiro A; Tzadok S; Rosenberg A; Inbal A; Bar-Natan M; Wolach O; Raanani P
    Acta Haematol; 2017; 137(4):183-190. PubMed ID: 28419992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
    Heckman KD; Weiner GJ; Davis CS; Strauss RG; Jones MP; Burns CP
    J Clin Oncol; 1997 Mar; 15(3):1143-9. PubMed ID: 9060557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of definitions and mechanisms of refractoriness to platelet transfusions.
    Hester JP; Ventura GJ
    Prog Clin Biol Res; 1990; 337():49-58. PubMed ID: 2191338
    [No Abstract]   [Full Text] [Related]  

  • 16. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. The use of platelet transfusions.
    Feusner J
    Am J Pediatr Hematol Oncol; 1984; 6(3):255-60. PubMed ID: 6393789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
    N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet transfusion therapy and circulating immune complexes.
    Safai-Kutti S; Zaroulis CG; Day NK; Good RA; Kutti J
    Vox Sang; 1980 Jul; 39(1):22-7. PubMed ID: 7445473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet transfusion: a dose-response study.
    Norol F; Bierling P; Roudot-Thoraval F; Le Coeur FF; Rieux C; Lavaux A; Kuentz M; Duedari N
    Blood; 1998 Aug; 92(4):1448-53. PubMed ID: 9694735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.